Extensive symptomatic chondral and osteochondral lesions in the knee are painful and
debilitating and, left untreated, inevitably progress to posttraumatic osteoarthritis
and whole-joint disease. The impact of this increasingly prevalent problem in terms
of health care costs and lost productivity is enormous, with associated costs estimated
at more than $200 billion in the United States alone.[1] For older and more sedentary patients, total knee arthroplasty (TKA) is commonly
used to address late-stage cartilage loss such that approximately 800,000 TKAs are
performed annually, with a projected 565% increase in primary TKAs by 2050.[2] However, young and active patients are not ideal candidates for TKA based on implant
longevity, complications, morbidity, and risk for revision, such that treatment strategies
at restoring missing hyaline cartilage and bone are highly desired for this patient
population.
Fresh osteochondral allograft (OCA) transplantation has been developed as a treatment
method for large (> 2.5 cm2) focal full-thickness articular cartilage lesions, particularly of the femoral condyles.
Outcomes after OCA transplantation in the knee have been moderately successful with
between 71 and 85% ten-year survivorship and approximately 74% fifteen-year survivorship
reported.[3]
[4] Patients with more substantial lesions involving two articulating surfaces such
that bipolar OCA transplantation is indicated have historically had less favorable
reported 10- to 15-year survivorship rates between 40 and 70%, meaning that between
30 and 60% of bipolar OCAs either failed or required revision.[3]
[4] Need for revision or salvage (TKA) surgery was often the result of OCA cartilage
erosion or delamination, or cartilage loss in nontransplanted areas of the knee. As
such, many surgeons abandoned performing bipolar grafts due to these disappointing
results.
In 2016, a novel graft preservation technique (Missouri Osteochondral Preservation
System [MOPS], MTF Biologics, Edison, NJ) was validated and became commercially available.
It yields remarkably improved chondrocyte viability in OCAs at the time of transplantation
and at least doubles their shelf life.[5] This advance in OCA preservation technology in conjunction with technical improvements
in surgical techniques fostered a progressive shift in the senior author's practice
to provide options for young or active patients with extensive symptomatic chondral
and osteochondral lesions in the knee to include multisurface and bipolar OCA transplantation.
Surgical Techniques
The technical improvements in surgical techniques that have evidence for improving
OCA transplantation for treatment of extensive cartilage lesions include:
-
cutting grafts thin (6–7 mm total thickness);
-
changes in graft shape to shell grafts in most cases;
-
creating a keel, or tab, on the grafts to allow for three-dimensional fit and stability
in the recipient site;
-
drilling channels into the OCA bone;
-
extensively irrigating the OCA bone with saline;
-
soaking the OCA cancellous bone with autologous bone marrow aspirate concentrate (BMAC);
-
stabilizing the grafts using bioabsorbable pins and nails; and
-
prescribed and monitored patient-specific rehabilitation protocols.[6]
[7]
[8]
Patients are placed supine on a radiolucent table. A midline approach is made with
either a medial or lateral parapatellar arthrotomy depending upon the articular surfaces
in the knee being treated. A Jamshidi needle is then inserted into the distal femur
and 45 to 120 mL of bone marrow aspirate (BMA) is collected. It is very important
to draw the BMA slowly and move the needle to optimize cell recovery. The BMA is processed
in the operating room to obtain BMAC using a commercially available validated system
(Angel System, Arthrex, Inc., Naples, FL) for subsequent treatment of OCA bone for
the indication of delivery of bone graft materials to an orthopaedic surgical site.
If the patient requires transplant of the medial or lateral tibial plateau, the first
cuts are made there. We use a reciprocating saw under fluoroscopic guidance to make
a vertical cut to approximately 7 mm depth at the margin of the respective hemiplateau,
taking care to avoid damaging the cruciate ligaments. A good lateral fluoroscopic
view is obtained and a sagittal saw is used to resect 6 to 7 mm of tibial plateau
and the associated remnant meniscus. Fluoroscopic guidance is used to match the respective
tibial slope and to prevent damage to associated soft tissue and neurovascular structures.
The sagittal saw is used to create a slot at the margin of the tibial recipient site
to accept the keel on the OCA.
For bipolar femoral condyle-meniscotibial OCA transplants, the next step is to identify
the area of articular cartilage damage on the femoral condyle. If it can be treated
with a single dowel graft, we use commercially available instrumentation and methods
to address the femoral lesion in that way. If the femur is not amenable to a single
circular dowel graft based on size, geometry, or location, we cut a shell graft that
encompasses all grossly affected articular cartilage. The sagittal saw is used to
create a slot at the margin of the femoral recipient site to accept the keel on the
OCA.
Custom-cut tibial plateau and femoral grafts are prepared using measurements from
the recipient site and the resected tissue in conjunction with using the resected
portions as templates, when possible. The grafts are made 6 to 7 mm thick, and both
the tibial plateau and the femur have a three-dimensional “keel,” or tab, to allow
for fit and stability in the recipient site ([Fig. 1]).
Fig. 1 Damaged tibial plateau (left) is template to cut fresh tibial plateau graft (right)
with keel and drilled channels for bone marrow aspirate concentrate.
If the patient has significant lesions of the patella and/or trochlea, we resect the
entire articular surface to completely resurface it with a size-matched patella or
trochlea OCA ([Fig. 2]). The initial patellar resection normally leaves a distal shelf of bone and cuts
a proximal slot. The trochlear resection is performed from lateral and medial trochlear
ridges to create a V-shaped recipient bed. Custom-cut grafts are prepared using measurements
from the recipient site and the resected tissue in conjunction with using the resected
portions as templates, when possible. The grafts are made 6 to 7 mm thick and the
patella includes a three-dimensional “keel,” or tab, to allow for fit and stability
in the recipient site.
Fig. 2 Complete patella replacement graft (left) and damaged articular surface (right).
When all damaged cartilage has been resected and recipient sites prepared in the patient,
we begin by transplanting the femoral condyle shell allograft. We make “finishing
cuts” on the graft and patient as needed to create a near-perfect fit. When the best
fit possible has been achieved, channels are drilled into the OCA cancellous bone
using a 3.2-mm drill bit. The OCA bone is thoroughly irrigated with 1 L of isotonic
saline using a power irrigator (e.g., InterPulse, Stryker, Kalamazoo, MI). The graft
bone is then saturated with the BMAC ([Fig. 3]). The graft is then fixed in place using bioabsorbable nails and/or pins (e.g.,
Smart Nails, ConMed Utica, NY; BioPins, Arthrex, Naples, FL). This process is repeated
for the tibial plateau with meniscus allograft. Great care must be used when implanting
the tibial plateau to avoid damage to the meniscus allograft. In rare circumstances,
we have used a femoral distractor to assist in opening the compartment to facilitate
tibial plateau placement. The tibial graft is fixed in place using bioabsorbable nails
and/or pins. The next OCA transplanted is normally the trochlea. Again, we make finishing
cuts to the graft and patient to obtain the best possible fit. Channels are drilled
and the OCA cancellous bone is saturated with BMAC. The graft is fixed into place
using bioabsorbable nails and/or pins. Finally, the patella is resurfaced with the
patellar OCA. After finishing cuts have been completed, channels have been drilled,
and the OCA bone has been irrigated and then saturated with BMAC, the graft is fixed
in place with bioabsorbable pins (Arthrex). Patellar tracking through range of motion
is assessed and the retinaculum is repaired with suture. The meniscus allograft is
attached to the patient's joint capsule using “outside-in” vertical mattress sutures
of 0 Vicryl. The meniscotibial allografts we use retain the meniscotibial ligament,
which we believe is crucial to success.[7] We then place the arthroscope into the knee and assess the meniscal stability. If
necessary, we place an “all inside” suture posteriorly or “inside-out” sutures more
anteriorly. It is rare that we require more than one or two arthroscopically placed
sutures. The wound is then thoroughly irrigated and closed.
Fig. 3 Soaking patella graft with bone marrow aspirate concentrate after drilling holes.
Our rehabilitation protocol generally involves toe touch weight bearing for 6 to 8
weeks, then 25% for 2 weeks, 50% for 2 weeks, and 75% for 2 weeks. Between the third
and fourth postoperative month the patient is allowed to weight bear as tolerated
and they continue to regain full motion. Radiographs are obtained at 3 months. If
they look good, the patient is allowed to slowly begin use of an exercise bicycle
after 4 months. At 6 months postop, if radiographs look good, they are advanced to
an elliptical machine. We monitor activities carefully until 12 months postop, avoiding
any impact or shearing forces. When the patient reaches 12 months and if the grafts
look good, we allow the slow introduction of a single activity involving either impact
or shear.[8]
To mitigate described complications and optimize outcomes after OCA transplantation
for extensive chondral and osteochondral lesions in the knee, our institution developed
a novel graft preservation system as previously described.[5]
[8]
[9]
[10]
[11]
[12]
[13] Implementation of this OCA preservation technology and technical improvements in
surgical techniques fostered a progressive shift in practice to provide options for
young and active patients with extensive cartilage lesions in the knee. To effectively
evaluate this progressive shift in practice in real time, all patients willing to
consent to enrollment were included in a prospective registry to track, analyze, and
report outcomes after OCA and meniscus allograft transplantation. With institutional
review board approval and informed consent, data from patients prospectively enrolled
into the registry with ≥ 1-year follow-up data, including complications, reoperations,
revisions, failures, patient-reported outcome measures (PROMs), and compliance with
rehabilitation after fresh primary unipolar, multisurface, and bipolar OCA transplantations
in the knee during the first 4 years of our registry have been reported.[6]
[8]
For the longest-term outcomes from our prospective registry to date,[6] 194 patients met inclusion criteria with 62% of cases undergoing bipolar OCA transplantation.
Mean age was 37.9 ± 12.2 (14–69) years and mean body mass index was 28.9 ± 5 (17–46)
kg/m2. In total, 26% of patients underwent concurrent or staged procedures in the same
knee addressing comorbidities such as lower extremity malalignment or knee ligament
deficiencies. Significant and clinically meaningful improvements in PROMs were noted
at 3 and 4 years after OCA transplantation for this cohort of patients. When comparing
PROMs between patients receiving MOPS-preserved grafts versus standard preservation
(SP) grafts, mean International Knee Documentation Committee (IKDC), Single Assessment
Numeric Evaluation, and Patient-Reported Outcomes Measurement Information System (PROMIS)
mobility scores were significantly higher for MOPS cases at 3 years postoperatively.
Initial success rates, defined as patients reporting return to functional activities
with no need for revision or conversion to TKA, were 79% for all cases combined and
84% for MOPS cases. Revisions were performed in 10% of all cases and 5% of MOPS cases.
Failures requiring conversion to TKA occurred in 13% of all cases and 11% of MOPS
cases, with bipolar OCA transplantations being significantly more likely to fail.
The majority of failures (65%) occurred between 6 and 12 months after surgery at a
mean time of 11 months. Patients who received SP grafts had been on the waiting list
for MOPS grafts but had not had a size-matched graft identified using MOPS preservation
when a size-matched SP graft that was less than 22 days from harvest was identified.
Patients were given the option of continuing to wait for a MOPS graft or move forward
with the SP graft that fit their needs. The demographics of the two groups were similar.
Direct comparisons between SP and MOPS cohorts highlights the consistently superior
results associated with OCA transplantation with grafts stored using the novel preservation
method ([Table 1]).[6]
Table 1
Results according to preservation method (SP n = 57, MOPS n = 137)
|
SP
|
MOPS
|
p
|
|
Success rates
|
60%
|
84%
|
0.028
|
|
Revisions
|
21%
|
5%
|
0.0014
|
|
Failures
|
19%
|
11%
|
0.048
|
|
VCD
|
49%
|
102%
|
< 0.05
|
|
6-mo KM survival
|
98.2 (89–99)
|
98.5 (94–100)
|
ns
|
|
1 y KM-survival
|
90.8 (80–97)
|
92.0 (86–96)
|
ns
|
|
4 y KM-survival
|
77.5 (65–87)
|
89.0 (82–94)
|
ns
|
Abbreviations: KM, Kaplan–Meier; MOPS, Missouri Osteochondral Preservation System;
ns, no statistically significant difference; SP, standard preservation; VCD, viable
chondrocyte density.
Bipolar transplants were defined as involving two opposing articulating surfaces,
including patellofemoral, femorotibial, and/or femoromeniscal compartments. For patients
in the registry study, 58 and 64% received bipolar OCA transplants in the SP and MOPS
cohorts, respectively, with 65% involving more than one compartment. The initial bipolar
success rates were 49% for SP OCAs versus 80% for MOPS OCAs, such that MOPS bipolar
cases were 4.1 times more likely than SP bipolar cases to be associated with successful
outcomes without need for revision at ≥ 1 year after transplantation. Failures occurred
in 19% of SP cases and 15% of MOPS cases corresponding to a significantly lower failure
rate for primary MOPS OCAs.[6] The data presented above is for 1- to 4-year follow-up as stated. It is highly likely
that there will be some additional failures as time goes by, although most studies,
and our experience, is that the overwhelming majority of failures occur within the
first 18 months.
Importantly, patients who were noncompliant with the prescribed postoperative protocol
during the first year after surgery were 6.7 times more likely to experience OCA transplantation
failure. In fact, 46% of patients requiring TKA in the course of the study were documented
to be noncompliant during the first postoperative year. These findings confirmed data
from a previous study showing that compliance with procedure-specific postoperative
rehabilitation protocols was associated with higher success, lower revision, and lower
failure rates for patients at 1 to 3 years after osteochondral and meniscal allograft
transplantation. As such, we have instituted, and highly recommend, behavioral screening,
adapted patient education, and careful monitoring and counseling to positively influence
this modifiable and highly relevant risk factor.[8]
[14]
Results to Date
The most recent systematic review by Melugin et al[15] reported outcomes and complications for treatment of bipolar cartilage lesions of
the knee including 156 OCAs in addition to cases treated using autologous chondrocyte
implantation or OCA transfer. For these cases, improvement in mid-term patient-reported
outcomes was noted and OCA survivorship ranged from 40 to 100%. Bulk allografts and
tibiofemoral compartment transplants were associated with higher failure rates. In
addition, concomitant procedures were commonly performed along with OCA transplantation.
A systematic review by Familiari et al[4] reported patient outcomes after all types of OCA transplantation surgeries in the
knee with an overall 10-year survival rate of 78.8%. Revision cases, patellar, and
bipolar OCA transplantations were associated with worse results including a reoperation
rate of 30.2% and a failure rate of 18.2%. Chahal et al[3] reported a similar failure rate but a complication rate of only 2.4% with favorable
outcomes and high satisfaction rates in short-term follow-up for focal and diffuse
single-compartment chondral defects treated by OCA transplantation. Other reviews
indicate that OCA transplantation is particularly appropriate for young and athletic
patients with favorable return-to-sports rates between 75 and 82%.[16]
[17]
[18] Importantly, bipolar OCA in the tibiofemoral compartment prolongs time to TKA and
provides good overall function.[15]
[19]
[20] Taken together, best current evidence suggests that the highest rates of successful
OCA transplantation are observed in younger patients, unipolar lesions, normal or
corrected limb alignment, and defects that are treated within 12 months of symptom
onset.[17] While bipolar OCA transplantation is not indicated for treatment of end-stage degenerative
knee OA, recent data supports its use for early intervention of extensive cartilage
loss from other causes, especially in combination with meniscus allograft transplantation,
demonstrating significant clinical improvements in cases with graft survival.[19]
[21]
[22] Importantly, Cotter et al have shown that the multiplug or “snowman” technique is
associated with inferior results while fresh large osteochondral shell allograft transplantation
in combination with concomitant procedures allows for an anatomical restoration of
osteochondral knee defects with good clinical outcomes.[23]
[24]
[25]
[26] Prospective assessment of outcomes after OCA transplantations in the knee at our
institution have recently been reported.[6]
In sum, the initial prospective registry data indicate that the implementation of
a novel OCA preservation method that maintains high viable chondrocyte density to
time of transplantation combined with modified surgical techniques and patient management
protocols leads to consistently successful outcomes for unipolar, multisurface, and
also bipolar OCA transplantations in the knee. This study provides further evidence
that fresh OCA transplantation represents an appropriate treatment option for young
and active patients with large full-thickness articular cartilage defects of the knee.[6]
Case Example
A 25-year-old male who was involved in a significant motor vehicle collision sustaining
a severe tibial plateau crush fracture status post more than 20 surgical procedures
presented for a salvage assessment. Prior to presentation, physical therapy, nonsteroidal
anti-inflammatory medications, and nonweight bearing via crutches were used to offset
intense pain. At presentation, physical examination, radiographic imaging, and diagnostic
arthroscopic assessment revealed knee range of motion of 0-0-80 degrees, proximal
tibial malunion with significant bone deformity, and extensive full-thickness posttraumatic
articular cartilage lesions in all compartments of his left knee with no functional
meniscal remnants ([Fig. 4]). After consultation with the patient and immediate family members with comprehensive
discussion of treatment options including TKA, arthrodesis, amputation, and osteochondral
and meniscal allograft transplantation, he opted and provided fully informed consent
for the following procedures: Left fresh MOPS-preserved OCA transplantation of the
medial femoral condyle, lateral femoral condyle, trochlea, patella, medial tibial
plateau, and lateral tibial plateau with arthroscopic-assisted transplant of the medial
meniscus and lateral meniscus, supplemented with bone grafting of the OCA-recipient
bone interfaces using autologous bone obtained from the patient's femur using a reamer
irrigator aspirator. He was followed-up at 1 month, 3, 7, and 9 months, and 1 and
2 years postoperatively. Range of motion consistently improved to a flexion of 95 degrees
after 1 year and 102 degrees after 2 years ([Fig. 5]). Radiographs ([Fig. 6]) and computed tomography ([Fig. 7]) showed good graft incorporation, IKDC improved from initial 10 to 42.5 after 1
year, and pain scores decreased to 0.5 from an initial value of 7.5. The patient strictly
adhered to the postoperative protocol.
Fig. 4 Preoperative imaging of the left knee following severe tibial plateau fracture with
full-thickness cartilage loss and meniscus loss from all compartments with distinctive
bone deformity but adequate alignment.
Fig. 5 Postoperative radiographs following all compartmental fresh osteochondral allograft
of the left knee including both mensici: (A, B) directly postoperative anteroposterior and lateral radiographs; (C) both knees anteroposterior 1 month postoperatively; (D) anteroposterior 3 months postoperatively; (E, F) anteroposterior and lateral 7 months postoperatively; (G) anteroposterior 9 months postoperatively.
Fig. 6 One-year postoperative radiographs after partial hardware removal (prominent tubercle
screw of left proximal tibia had led to associated pain).
Fig. 7 (A-F) Computed tomography scans (first row – 3 months and second row – 1 year postoperatively)
demonstrating good graft incorporation.
Future Applications
OCA transplantation has undergone extensive basic, preclinical, and clinical research
for progressive development over the last four decades and its use is steadily increasing
in the United States.[4] In spite of significant clinical improvements in pain and function in cases with
successful graft healing, integration, and remodeling, moderate to high failure rates
persist.[3]
[4]
[27] Currently, no other consistently successful treatment options are available for
young or active patients with extensive symptomatic chondral and osteochondral lesions
in the knee, which leads to a critical unmet need in orthopaedic health care.[6]
[27]
[28] Our novel and comprehensive approach was designed to address this need based on
translational research and prospective clinical assessments. As noted in our data,
failures can and will occur in these complicated patients. While the number of failures
appears to be decreasing compared with prior literature, they do occur and generally
require either a revision of the graft transplant procedure or a conversion to a total
joint arthroplasty. Both have been done successfully in our patient cohort. Further
follow-up with documentation of long-term outcomes will provide insight for continued
optimization for future applications for OCA transplantation, potentially including
a broader spectrum of patients appropriate for this treatment. This comprehensive
approach has already been successfully applied to “bipolar and beyond” OCA transplantation
in patients' ankle and hip joints and has preclinical evidence for application to
the upper extremity, including shoulder, elbow, and phalangeal joints.[29]
[30] Ongoing translational research is necessary to blaze the trail in further optimizing
this treatment option for patients.
